Pioneering Research. Life Changing Tests. Moleculera Labs provides a next-generation antibody test called The Cunningham Panel™. The Cunningham Panel™ helps physicians identify whether an autoimmune dysfunction may be causing a person’s neuropsychiatric symptoms. The panel measures levels of autoantibodies attacking certain proteins in the brain, including those that stimulate brain cells to increase production of excess neurotransmitters, triggering inflammation and abnormal behaviors. High levels of these autoantibodies indicate an individual may have an infection-induced autoimmune disorder.
